Maxim Group Downgrades Helius Medical Tech to Hold
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Anthony Vendetti has downgraded Helius Medical Technologies (NASDAQ:HSDT) from a Buy to a Hold rating.
October 16, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Maxim Group has downgraded Helius Medical Technologies from a Buy to a Hold, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold by a reputable analyst suggests a less favorable view on HSDT's short-term performance, likely leading to a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100